Cargando…

NAD(+) Metabolism and Interventions in Premature Renal Aging and Chronic Kidney Disease

Premature aging causes morphological and functional changes in the kidney, leading to chronic kidney disease (CKD). CKD is a global public health issue with far-reaching consequences, including cardio-vascular complications, increased frailty, shortened lifespan and a heightened risk of kidney failu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chanvillard, Lucie, Tammaro, Alessandra, Sorrentino, Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818486/ https://www.ncbi.nlm.nih.gov/pubmed/36611814 http://dx.doi.org/10.3390/cells12010021

Ejemplares similares

Roles of NAD(+) in Acute and Chronic Kidney Diseases
por: Morevati, Marya, et al.
Publicado: (2022)

Inflammation and Premature Ageing in Chronic Kidney Disease
por: Ebert, Thomas, et al.
Publicado: (2020)

Early aging and premature vascular aging in chronic kidney disease
por: Tanriover, Cem, et al.
Publicado: (2023)

Impact of NAD+ metabolism on ovarian aging
por: Liang, Jinghui, et al.
Publicado: (2023)

The Central Role of the NAD+ Molecule in the Development of Aging and the Prevention of Chronic Age-Related Diseases: Strategies for NAD+ Modulation
por: Poljšak, Borut, et al.
Publicado: (2023)

Potential of Polyphenols to Restore SIRT1 and NAD+ Metabolism in Renal Disease
por: Tovar-Palacio, Claudia, et al.
Publicado: (2022)

NAD (+) biosynthesis, aging, and disease
por: Johnson, Sean, et al.
Publicado: (2018)

Targeting NAD(+) Metabolism as Interventions for Mitochondrial Disease
por: Lee, Chi Fung, et al.
Publicado: (2019)

NAD(+) homeostasis in renal health and disease
por: Ralto, Kenneth M., et al.
Publicado: (2019)

NAD(+) Metabolism and Diseases with Motor Dysfunction
por: Lundt, Samuel, et al.
Publicado: (2021)

Premature Aging in Chronic Kidney Disease: The Outcome of Persistent Inflammation beyond the Bounds
por: Figuer, Andrea, et al.
Publicado: (2021)

The Circadian NAD(+) Metabolism: Impact on Chromatin Remodeling and Aging
por: Nakahata, Yasukazu, et al.
Publicado: (2016)

Implications of NAD(+) Metabolism in the Aging Retina and Retinal Degeneration
por: Jadeja, Ravirajsinh N., et al.
Publicado: (2020)

NADH/NAD(+) Redox Imbalance and Diabetic Kidney Disease
por: Yan, Liang-Jun
Publicado: (2021)

Enzymology of extracellular NAD metabolism
por: Gasparrini, Massimiliano, et al.
Publicado: (2021)

Premature Aging of the Microcirculation in Patients with Advanced Chronic Kidney Disease
por: Thang, Oanh H.D., et al.
Publicado: (2012)

NAD metabolism modulates inflammation and mitochondria function in diabetic kidney disease
por: Myakala, Komuraiah, et al.
Publicado: (2023)

Emerging therapeutic roles for NAD(+) metabolism in mitochondrial and age-related disorders
por: Srivastava, Sarika
Publicado: (2016)

NAD(+) Homeostasis in Diabetic Kidney Disease
por: Xu, Jing, et al.
Publicado: (2021)

The significance of NAD + metabolites and nicotinamide N-methyltransferase in chronic kidney disease
por: Takahashi, Rina, et al.
Publicado: (2022)

Implications of altered NAD metabolism in metabolic disorders
por: Okabe, Keisuke, et al.
Publicado: (2019)

Premature coronary artery disease and early stage chronic kidney disease
por: Price, A M, et al.
Publicado: (2018)

NAD(+) boosting reduces age-associated amyloidosis and restores mitochondrial homeostasis in muscle
por: Romani, Mario, et al.
Publicado: (2021)

Parathyroid hormone and premature thymus ageing in patients with chronic kidney disease
por: Iio, Kenichiro, et al.
Publicado: (2019)

Circadian cardiac NAD(+) metabolism, from transcriptional regulation to healthy aging
por: Carpenter, Bryce J., et al.
Publicado: (2022)

The Role of Kynurenine Pathway and NAD(+) Metabolism in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Dehhaghi, Mona, et al.
Publicado: (2022)

The complexity of nicotinamide adenine dinucleotide (NAD), hypoxic, and aryl hydrocarbon receptor cell signaling in chronic kidney disease
por: Curran, Colleen S., et al.
Publicado: (2023)

NAD(+), Senolytics, or Pyruvate for Healthy Aging?
por: Zhou, Fang-Qiang
Publicado: (2021)

Renal Tissue Oxygenation in Essential Hypertension and Chronic Kidney Disease
por: Pruijm, Menno, et al.
Publicado: (2013)

Regulation of Glucose Metabolism by NAD(+) and ADP-Ribosylation
por: Hopp, Ann-Katrin, et al.
Publicado: (2019)

NAD(+) Metabolism and Regulation: Lessons From Yeast
por: Croft, Trevor, et al.
Publicado: (2020)

NAD(+) metabolism-based immunoregulation and therapeutic potential
por: Fang, Jiankai, et al.
Publicado: (2023)

Targeting NAD+ in Metabolic Disease: New Insights Into an Old Molecule
por: Elhassan, Yasir S., et al.
Publicado: (2017)

Metabolic syndrome in children with chronic kidney disease and after renal transplantation
por: Litwin, Mieczysław, et al.
Publicado: (2013)

Role of PGC-1α in the Mitochondrial NAD(+) Pool in Metabolic Diseases
por: Koh, Jin-Ho, et al.
Publicado: (2021)

Tolerance to NADH/NAD(+) imbalance anticipates aging and anti-aging interventions
por: Alonso-Lavin, Alvar J., et al.
Publicado: (2021)

Metabolic bone disease of prematurity()
por: Rustico, Stacy E., et al.
Publicado: (2014)

The human NAD metabolome: Functions, metabolism and compartmentalization
por: Nikiforov, Andrey, et al.
Publicado: (2015)

NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential
por: Xie, Na, et al.
Publicado: (2020)

NAD(+) metabolism, stemness, the immune response, and cancer
por: Navas, Lola E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5ep7mo0hq9js1qktgfmr0u3ao8